Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Molecular Medicine

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ijmm.2015.2388PMID 26497897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR‐204, down‐regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP‐9

  2015cited by this paper
• The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients

  2015cited by this paper
• MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer

  2015cited by this paper
• Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.

  2014cited by this paper
• MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma

  2014cited by this paper
• MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A

  2014cited by this paper
• MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1

  2014cited by this paper
• Down‐regulation of miRNA‐204 by LMP‐1 enhances CDC42 activity and facilitates invasion of EBV‐associated nasopharyngeal carcinoma cells

  2014cited by this paper
• Clinical relevance of circulating cell-free microRNAs in cancer

  2014cited by this paper
• Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4

  2014cited by this paper
• miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A

  2014cited by this paper
• miR‐204 functions as a tumor suppressor by regulating SIX1 in NSCLC

  2014cited by this paper
• Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer

  2014cited by this paper
• Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

  2014cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• A TrkB–STAT3–miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells

  2013cited by this paper
• Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer

  2013cited by this paper
• MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4.

  2013cited by this paper
• Determination of plasma microRNA for early detection of gastric cancer

  2013cited by this paper
• Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

  2013cited by this paper
• Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization

  2012cited by this paper
• miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

  2012cited by this paper
• MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

  2012cited by this paper
• Clinical trials and biomarker research on lung cancer in China

  2012cited by this paper
• MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

  2012cited by this paper
• Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

  2012cited by this paper
• Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling

  2012cited by this paper
• MicroRNAs in body fluids—the mix of hormones and biomarkers

  2011cited by this paper
• Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells.

  2011cited by this paper
• Detection of microRNAs in dried serum blots.

  2010cited by this paper
• MicroRNAs and metastasis: little RNAs go a long way.

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection

  2008cited by this paper
• microRNAs as oncogenes and tumor suppressors.

  2007cited by this paper
• MicroRNA expression and function in cancer.

  2006cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Prognostic value of pretreatment CEA, SCC‐Ag and CA 19–9 levels in sera of patients with non‐small cell lung cancer

  1992cited by this paper

• Risk factors and mechanisms of immune checkpoint inhibitor-related pneumonitis

  2025cites this paper
• Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma

  2023cites this paper
• miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

  2023cites this paper
• Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC

  2023cites this paper
• Expression of microRNAs in leukocytes and serum of asbestosis patients

  2023cites this paper
• Development of Electrochemical Biosensor for miR204-Based Cancer Diagnosis

  2022cites this paper
• MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

  2021cites this paper
• Study on Serum miR-204 Expression Levels in Patients with Severe Pneumonia and Patients with Primary Bronchial Lung Cancer and Its Diagnostic Value

  2021cites this paper
• High Diagnostic and Prognostic Value of miRNAs Compared with the Carcinoembryonic Antigen as a Traditional Tumor Marker.

  2021cites this paper
• MicroRNAs: Key Regulators in Lung Cancer.

  2021cites this paper
• LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis

  2021cites this paper
• Downregulation of miR-26b-5p, miR-204-5p, and miR-497-3p Expression Facilitates Exercise-Induced Physiological Cardiac Hypertrophy by Augmenting Autophagy in Rats

  2020cites this paper
• LncRNA NEAT1/miR-204/NUAK1 Axis is a Potential Therapeutic Target for Non-Small Cell Lung Cancer

  2020cites this paper
• miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.

  2020cites this paper
• [Effect of miR-204-5p on the proliferation, migration, and invasion on tongue squamous cell carcinoma SCC25 cells by targeting bromodomain-containing protein 4].

  2020cites this paper
• Serum level of long noncoding RNA B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer.

  2020cites this paper
• Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses

  2020influential citation
• Circulating microRNA‐590‐5p functions as a liquid biopsy marker in non‐small cell lung cancer

  2020cites this paper
• Regulation of phagolysosomal activity by miR-204 critically influences retinal pigment epithelium/retinal structure and function.

  2019cites this paper
• Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations

  2019cites this paper
• Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas

  2019cites this paper
• Recent advances in biosensor for detection of lung cancer biomarkers.

  2019cites this paper
• Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.

  2019cites this paper
• Overexpression of LIMD 2 promotes the progression of non ‐ small cell lung cancer

  2019cites this paper
• Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage

  2019cites this paper
• Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma

  2019cites this paper
• Clinical diagnostic value of combined detection of microRNA-373 and microRNA-204 expression in retinoblastoma

  2019cites this paper
• Prognostic value of microRNAs in lung cancer: A systematic review and meta-analysis

  2018cites this paper
• Triiodothyronine Promotes Cell Proliferation of Breast Cancer via Modulating miR-204/Amphiregulin

  2018cites this paper
• Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  2018cites this paper
• A review of microRNAs related to the occurrence, diagnosis, and prognosis of non-small cell lung cancer

  2018cites this paper
• MicroRNA‐204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2–signal transducer and activator of transcription 3 pathway

  2018cites this paper
• An interplay between MicroRNA and SOX4 in the regulation of epithelial–mesenchymal transition and cancer progression

  2018cites this paper
• Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.

  2018cites this paper
• MicroRNA-204 inhibits the proliferation, migration and invasion of human lung cancer cells by targeting PCNA-1 and inhibits tumor growth in vivo

  2018cites this paper
• Downregulation of miR-204 is associated with poor prognosis and promotes cell proliferation in hypopharyngeal squamous cell carcinoma (HSCC).

  2017cites this paper
• The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers

  2017cites this paper
• MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals

  2017cites this paper
• miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.

  2017cites this paper
• RETRACTED: Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patients.

  2017cites this paper
• A meta‐analysis: microRNAs’ prognostic function in patients with nonsmall cell lung cancer

  2017cites this paper
• The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics

  2017cites this paper
• Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients

  2017influential citation
• Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention.

  2016cites this paper
• Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

  2016cites this paper
• Epigenetics in non-small cell lung cancer: from basics to therapeutics.

  2016cites this paper
• Original Article Down-regulation of miR-182 and miR-183 acts as potential predictor biomarkers in progression, metastasis, and poor prognosis of non-small cell lung cancer

  2016cites this paper
• Down-regulation of miR-182 and miR-183 acts as potential predictor biomarkers in progression , metastasis , and poor prognosis of non-small cell lung cancer

  2016cites this paper
• Tumor suppressor miR-124 involved in stromal cells growth and apoptosis by targeting RANKL in giant cell tumor of bone

  2016cites this paper
• MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.

  2016cites this paper